133 related articles for article (PubMed ID: 7578871)
21. Nontoxic nodular goiter and papillary thyroid carcinoma are not associated with peripheral blood lymphocyte sensitization to thyroid cells.
Aguayo J; Sakatsume Y; Jamieson C; Row VV; Volpé R
J Clin Endocrinol Metab; 1989 Jan; 68(1):145-9. PubMed ID: 2462573
[TBL] [Abstract][Full Text] [Related]
22. Follicular thyroid cells of autoimmune thyroiditis may coexpress ICAM-1 (CD54) and its natural ligand LFA-1 (CD11a/CD18).
Bagnasco M; Pesce GP; Caretto A; Paolieri F; Pronzato C; Villaggio B; Giordano C; Betterle C; Canonica GW
J Allergy Clin Immunol; 1995 May; 95(5 Pt 1):1036-43. PubMed ID: 7751500
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical localization of inducible and endothelial constitutive nitric oxide synthase in neoplastic and autoimmune thyroid disorders.
Kayser L; Francis D; Broholm H
APMIS; 2000 Nov; 108(11):785-91. PubMed ID: 11211974
[TBL] [Abstract][Full Text] [Related]
24. Thyroglobulin synthesis of oxyphilic cells in various types of neoplastic and autoimmune thyroid diseases.
Hwang TS; Suh JS; Kim YI; Park SH; Cho BY; Koh CS
J Korean Med Sci; 1990 Mar; 5(1):33-7. PubMed ID: 1698387
[TBL] [Abstract][Full Text] [Related]
25. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis.
Matsubayashi S; Akasu F; Kasuga Y; Snow K; Keystone E; Volpé R
Clin Exp Immunol; 1990 Oct; 82(1):63-8. PubMed ID: 1976464
[TBL] [Abstract][Full Text] [Related]
26. Intrathyroidal cytokine gene expression profiles in autoimmune thyroiditis.
Paschke R; Schuppert F; Taton M; Velu T
J Endocrinol; 1994 May; 141(2):309-15. PubMed ID: 8046301
[TBL] [Abstract][Full Text] [Related]
27. Estrogen and estrogen receptors in thyroid carcinomas.
Mizukami Y; Michigishi T; Nonomura A; Hashimoto T; Noguchi M; Matsubara F
J Surg Oncol; 1991 Jul; 47(3):165-9. PubMed ID: 2072699
[TBL] [Abstract][Full Text] [Related]
28. HLA class II antigen expression and the autoimmune thyroid response in patients with benign and malignant thyroid tumors.
Goldsmith NK; Dikman S; Bermas B; Davies TF; Roman SH
Clin Immunol Immunopathol; 1988 Aug; 48(2):161-73. PubMed ID: 3390969
[TBL] [Abstract][Full Text] [Related]
29. [Bcl-2 proto-oncogene expression in neoplastic and non neoplastic thyroid tissue].
Branet F; Caron P; Camallières M; Selves J; Brousset P
Bull Cancer; 1996 Mar; 83(3):213-7. PubMed ID: 8695923
[TBL] [Abstract][Full Text] [Related]
30. Do thyroid-stimulating immunoglobulins cause non-toxic and toxic multinodular goitre?
Brown RS; Jackson IM; Pohl SL; Reichlin S
Lancet; 1978 Apr; 1(8070):904-6. PubMed ID: 76846
[TBL] [Abstract][Full Text] [Related]
31. Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre.
Jansson R; Karlsson A; Forsum U
Clin Exp Immunol; 1984 Nov; 58(2):264-72. PubMed ID: 6238731
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of Fas, FasL and Caspase-8 expression in thyroid gland in young patients with immune and non-immune thyroid diseases].
Bossowski A; Czarnocka B; Stasiak-Barmuta A; Bardadin K; Urban M; Dadan J
Endokrynol Pol; 2007; 58(4):303-13. PubMed ID: 18058722
[TBL] [Abstract][Full Text] [Related]
33. [Ghrelin expression in the tissues of different thyroid diseases].
Zhang YF; Wang HN; Hong TP
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 38(2):193-6. PubMed ID: 16617365
[TBL] [Abstract][Full Text] [Related]
34. CD98 expression is decreased in papillary carcinoma of the thyroid and Hashimoto's thyroiditis.
Anderson CE; Graham C; Herriot MM; Kamel HM; Salter DM
Histopathology; 2009 Dec; 55(6):683-6. PubMed ID: 19922591
[TBL] [Abstract][Full Text] [Related]
35. [Behavior of antithyroglobulin and antimicrosomal antibodies in thyroid pathology].
Sussi PL; Burro A; Plebani M; Abrescia F; Perazzolo E; Petronio R
Chir Ital; 1984 Aug; 36(4):643-7. PubMed ID: 6549274
[TBL] [Abstract][Full Text] [Related]
36. The production and characterization of thyroid-derived T-cell lines in Graves' disease and Hashimoto's thyroiditis.
Weetman AP; Volkman DJ; Burman KD; Margolick JB; Petrick P; Weintraub BD; Fauci AS
Clin Immunol Immunopathol; 1986 Apr; 39(1):139-50. PubMed ID: 3485022
[TBL] [Abstract][Full Text] [Related]
37. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
Teng XD; Wang LJ; Yao HT; Li J; Ding W; Yan LP
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
[TBL] [Abstract][Full Text] [Related]
38. Tumor-specific deposition of immunoglobulin G and complement in papillary thyroid carcinoma.
Lucas SD; Karlsson-Parra A; Nilsson B; Grimelius L; Akerström G; Rastad J; Juhlin C
Hum Pathol; 1996 Dec; 27(12):1329-35. PubMed ID: 8958307
[TBL] [Abstract][Full Text] [Related]
39. Evidence of integrity of the follicular basement membrane in Hashimoto's thyroiditis.
Zantut-Wittmann DE; Zollner RL; Pinto GA; Vassallo J
Pathol Int; 1999 Dec; 49(12):1119-21. PubMed ID: 10632936
[TBL] [Abstract][Full Text] [Related]
40. [Hyperthyroidism and carcinoma of the thyroid gland].
Ardito G; Mantovani M; Vincenzoni C; Guidi ML; Corsello S; Rabitti C; Fadda G; Di Giovanni V
Ann Ital Chir; 1997; 68(1):23-7; discussion 27-8. PubMed ID: 9235859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
